Illumina to Webcast Live Presentation at the J.P. Morgan Annual Healthcare Conference  

SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (NASDAQ: ILMN) today announced that it will webcast the company’s presentation at the J.P. Morgan 35th Annual Healthcare Conference in San Francisco, California, on January 9, 2017. The live webcast is scheduled to begin at 10:30 AM PT and will feature a brief overview of the company by Francis deSouza, President and CEO, followed by a question and answer session.

The webcast can be accessed in the Investor Relations section of Illumina's web site under the "company" tab at www.illumina.com.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments. To learn more, visit www.illumina.com and follow @illumina.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161227005061/en/

Illumina, Inc.
Investors:
Rebecca Chambers, 858-255-5243
[email protected]
or
Media:
Eric Endicott, 858-882-6822
[email protected]

Source: Illumina, Inc.

You May Also Be Interested In

• Illumina (ILMN) PT Lowered to $125 at Baird
• FLYHT Reports Fourth Quarter and Full Year 2023 Results
• ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST